Skip to main content
. Author manuscript; available in PMC: 2019 Jul 9.
Published in final edited form as: Am J Kidney Dis. 2019 Jan 25;73(6):827–836. doi: 10.1053/j.ajkd.2018.11.010

Table 3.

Association Between Baseline Lipid and Apolipoprotein Levels and Atherosclerotic Cardiovascular Disease

HR (95% CI) P
Total cholesterol, per 1 SD greater 1.0S (0.92–1.14) 0.6
Non—HDL-C, per 1 SD lower 1.09 (0.99–1.21) 0.07
VLDL-C,a per 1 SD greater 1.09 (0.99–1.21) 0.07
Triglycerides,a per 1 SD greater 1.14 (1.0S-1.25) 0.01
LDL-C, per 1 SD greater 1.05 (0.94–1.16) 0.4
Apolipoprotein B, per 1 SD greater 1.09 (0.99–1.21) 0.08
HDL-C, per 1 SD greater 1.28 (1.09–1.59) 0.002
Apolipoprotein AI, per 1 SD lower 1.25 (1.07–1.45) 0.004

Note: Model adjusted for age, sex, race/ethnicity, clinical site, smoking, diabetes mellitus, body mass index, systolic blood pressure, statin use, estimated glomerular filtration rate, and 24-hour urine protein excretion.

Abbreviations: CI, confidence interval; HDL-C, high-density lipoprotein cholesterol; HR, hazard ratio; LDL-C, low-density lipoprotein cholesterol; non—HDL-C, non lowdensity lipoprotein cholesterol.

a

Values were natural-log transformed.